{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:49:18Z","timestamp":1791319758224,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ejso.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T12:09:20Z","timestamp":1448453360000},"page":"224-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center"],"prefix":"10.1016","volume":"42","author":[{"given":"F.C.","family":"Mu\u00f1oz-Casares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Medina-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Arjona-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Casado-Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"S\u00e1nchez-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ortega-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Mu\u00f1oz-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rufi\u00e1n-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Brice\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2015.11.006_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"Suppl. 1","key":"10.1016\/j.ejso.2015.11.006_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1525-1438.2005.15351.x","article-title":"Treatment goals in ovarian cancer","volume":"15","author":"Ozols","year":"2005","journal-title":"Int J Gynecol Cancer \u2013 Off J Int Gynecol Cancer Soc"},{"key":"10.1016\/j.ejso.2015.11.006_bib3","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1245\/s10434-012-2446-8","article-title":"Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer","volume":"19","author":"Chang","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejso.2015.11.006_bib5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2015.11.006_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"Suppl. 10","key":"10.1016\/j.ejso.2015.11.006_bib7","doi-asserted-by":"crossref","first-page":"x41","DOI":"10.1093\/annonc\/mdt469","article-title":"Intraperitoneal chemotherapy requires expertise and should be the standard of care for optimally surgically resected epithelial ovarian cancer patients","volume":"24","author":"Walker","year":"2013","journal-title":"Ann Oncol \u2013 Off J Eur Soc Med Oncol\/ESMO"},{"key":"10.1016\/j.ejso.2015.11.006_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","article-title":"Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis","volume":"14","author":"Sugarbaker","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib9","first-page":"753","article-title":"The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer","volume":"11","author":"Munoz-Casares","year":"2009","journal-title":"Clin Transl Oncol \u2013 Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"key":"10.1016\/j.ejso.2015.11.006_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2004.05.044","article-title":"Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer","volume":"94","author":"Ryu","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jso.20597","article-title":"Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer","volume":"94","author":"Rufian","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial","volume":"122","author":"Deraco","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib13","first-page":"1109","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later?","volume":"39","author":"Gonzalez Bayon","year":"2013","journal-title":"Eur J Surg Oncol \u2013 J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib14","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib15","first-page":"652","article-title":"Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals","volume":"9","author":"Munoz-Casares","year":"2007","journal-title":"Clin Transl Oncol \u2013 Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"key":"10.1016\/j.ejso.2015.11.006_bib16","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib17","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.1995.13.12.2961","article-title":"Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group Pilot Study","volume":"13","author":"Francis","year":"1995","journal-title":"J\u00a0Clin Oncol \u2013 Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib18","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.1998.16.8.2620","article-title":"Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study","volume":"16","author":"Markman","year":"1998","journal-title":"J\u00a0Clin Oncol \u2013 Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2015.11.006_bib20","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","article-title":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","volume":"50","author":"Elias","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2015.11.006_bib22","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1245\/s10434-014-3599-4","article-title":"Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC\/IV ovarian cancer","volume":"21","author":"Cascales-Campos","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1245\/s10434-007-9792-y","article-title":"Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study","volume":"15","author":"de Bree","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib24","first-page":"1435","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol \u2013 J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib25","first-page":"1186","article-title":"Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer \u2013 12-year single center experience","volume":"35","author":"Pavlov","year":"2009","journal-title":"Eur J Surg Oncol \u2013 J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4613-1245-1_8","article-title":"Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer","volume":"81","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2015.11.006_bib27","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2015.11.006_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejogrb.2014.05.018","article-title":"Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients","volume":"179","author":"Cascales-Campos","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejso.2015.11.006_bib29","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1245\/s10434-013-3053-z","article-title":"Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality","volume":"20","author":"Votanopoulos","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2013.12.002","article-title":"Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: safety and effectiveness","volume":"132","author":"da Costa Miranda","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2006.11.002","article-title":"Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction","volume":"104","author":"Bristow","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2015.11.006_bib32","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2015.11.006_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-011-1646-4","article-title":"Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study","volume":"68","author":"Munoz-Casares","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ejso.2015.11.006_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpba.2013.12.028","article-title":"LC-MS\/MS quantitative analysis of paclitaxel and its major metabolites in serum, plasma and tissue from women with ovarian cancer after intraperitoneal chemotherapy","volume":"91","author":"Fernandez-Peralbo","year":"2014","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.ejso.2015.11.006_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2015.11.006_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2013.04.001","article-title":"Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study","volume":"130","author":"Landrum","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315008847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315008847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T12:56:17Z","timestamp":1537188977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798315008847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0748798315008847"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2015.11.006","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}